Metro Healthcare Indonesia Tbk PT
IDX:CARE
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
75
193
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Metro Healthcare Indonesia Tbk PT
Balance Sheet
Balance Sheet Decomposition
Metro Healthcare Indonesia Tbk PT
| Current Assets | 720.4B |
| Cash & Short-Term Investments | 673.9B |
| Receivables | 35.8B |
| Other Current Assets | 10.7B |
| Non-Current Assets | 3.3T |
| PP&E | 3.3T |
| Intangibles | 7B |
| Other Non-Current Assets | 4.4B |
| Current Liabilities | 880B |
| Accounts Payable | 17.6B |
| Accrued Liabilities | 25B |
| Short-Term Debt | 794.4B |
| Other Current Liabilities | 43.1B |
| Non-Current Liabilities | 124.5B |
| Long-Term Debt | 115.7B |
| Other Non-Current Liabilities | 8.8B |
Balance Sheet
Metro Healthcare Indonesia Tbk PT
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
2 810
|
5 834
|
7 935
|
6 949
|
525 480
|
538 400
|
533 208
|
525 763
|
|
| Cash |
2 810
|
5 834
|
7 935
|
6 949
|
525 480
|
538 400
|
533 208
|
525 763
|
|
| Short-Term Investments |
0
|
5 462
|
0
|
220 000
|
200 000
|
654 000
|
320 000
|
229 000
|
|
| Total Receivables |
7 024
|
13 882
|
33 224
|
54 779
|
46 333
|
51 087
|
19 835
|
30 197
|
|
| Accounts Receivables |
7 024
|
13 850
|
33 208
|
54 612
|
46 316
|
43 419
|
19 494
|
29 763
|
|
| Other Receivables |
0
|
32
|
16
|
167
|
18
|
7 669
|
341
|
434
|
|
| Inventory |
1 282
|
2 504
|
3 867
|
6 281
|
6 868
|
6 129
|
3 810
|
4 778
|
|
| Other Current Assets |
226
|
1 396
|
612
|
4 144
|
3 172
|
4 644
|
4 769
|
4 781
|
|
| Total Current Assets |
11 342
|
29 077
|
45 639
|
292 154
|
781 853
|
1 254 261
|
881 622
|
794 519
|
|
| PP&E Net |
197 691
|
285 874
|
493 877
|
2 144 296
|
2 175 317
|
2 915 791
|
3 337 354
|
3 330 400
|
|
| PP&E Gross |
197 691
|
285 874
|
493 877
|
2 144 296
|
2 175 317
|
2 915 791
|
3 337 354
|
3 330 400
|
|
| Accumulated Depreciation |
7 237
|
37 796
|
44 895
|
53 190
|
65 310
|
121 230
|
130 277
|
151 629
|
|
| Goodwill |
11 921
|
11 921
|
11 921
|
7 024
|
7 024
|
6 972
|
6 972
|
6 972
|
|
| Other Long-Term Assets |
519
|
1 151
|
576
|
4 996
|
481 476
|
34 188
|
8 673
|
5 115
|
|
| Other Assets |
11 921
|
11 921
|
11 921
|
7 024
|
7 024
|
6 972
|
6 972
|
6 972
|
|
| Total Assets |
221 473
N/A
|
328 024
+48%
|
552 014
+68%
|
2 448 470
+344%
|
3 445 671
+41%
|
4 211 212
+22%
|
4 234 621
+1%
|
4 137 006
-2%
|
|
| Liabilities | |||||||||
| Accounts Payable |
2 854
|
1 954
|
8 120
|
8 086
|
13 169
|
14 657
|
26 876
|
42 533
|
|
| Accrued Liabilities |
1 375
|
1 015
|
3 621
|
6 148
|
9 096
|
21 127
|
30 292
|
25 368
|
|
| Short-Term Debt |
30 000
|
32 107
|
41 165
|
22 724
|
12 964
|
2 992
|
129 665
|
790 991
|
|
| Current Portion of Long-Term Debt |
8 731
|
13 724
|
19 845
|
6 801
|
7 502
|
15 382
|
19 672
|
33 865
|
|
| Other Current Liabilities |
135 511
|
219 214
|
422 253
|
21 738
|
5 698
|
23 502
|
6 498
|
10 891
|
|
| Total Current Liabilities |
178 471
|
268 014
|
495 004
|
65 497
|
48 429
|
77 659
|
213 002
|
903 647
|
|
| Long-Term Debt |
32 071
|
46 347
|
80 866
|
103 199
|
95 697
|
177 464
|
158 933
|
129 659
|
|
| Deferred Income Tax |
0
|
1 087
|
788
|
559
|
0
|
0
|
402
|
563
|
|
| Minority Interest |
50
|
12 346
|
1 096
|
1 070
|
923
|
1 017
|
984
|
1 225
|
|
| Other Liabilities |
309
|
1 241
|
2 496
|
6 076
|
10 788
|
657 821
|
655 392
|
5 414
|
|
| Total Liabilities |
210 801
N/A
|
329 035
+56%
|
580 249
+76%
|
176 401
-70%
|
155 836
-12%
|
913 961
+486%
|
1 028 713
+13%
|
1 040 507
+1%
|
|
| Equity | |||||||||
| Common Stock |
250
|
250
|
250
|
2 325 000
|
3 325 000
|
3 325 000
|
3 325 000
|
3 325 000
|
|
| Retained Earnings |
10 422
|
1 261
|
28 486
|
52 930
|
38 449
|
31 033
|
122 376
|
231 785
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
3 284
|
3 284
|
3 284
|
3 284
|
|
| Total Equity |
10 672
N/A
|
1 011
N/A
|
28 236
-2 692%
|
2 272 070
N/A
|
3 289 835
+45%
|
3 297 251
+0%
|
3 205 908
-3%
|
3 096 499
-3%
|
|
| Total Liabilities & Equity |
221 473
N/A
|
328 024
+48%
|
552 014
+68%
|
2 448 470
+344%
|
3 445 671
+41%
|
4 211 212
+22%
|
4 234 621
+1%
|
4 137 006
-2%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
23 250
|
23 250
|
23 250
|
23 250
|
33 250
|
33 250
|
33 250
|
33 250
|
|
You don't have any saved screeners yet
